Phreesia (NYSE:PHR) Stock Rating Reaffirmed by Truist Financial

Truist Financial reaffirmed their buy rating on shares of Phreesia (NYSE:PHR) in a research report sent to investors on Monday morning, Benzinga reports. Truist Financial currently has a $29.00 price objective on the stock.

PHR has been the topic of several other research reports. Raymond James reaffirmed an outperform rating and issued a $30.00 price objective (up previously from $25.00) on shares of Phreesia in a research note on Friday, March 15th. Stephens reissued an overweight rating and set a $28.00 target price on shares of Phreesia in a research note on Friday, May 31st. Royal Bank of Canada reissued a sector perform rating and set a $23.00 target price on shares of Phreesia in a research note on Thursday, March 21st. Robert W. Baird lifted their target price on Phreesia from $30.00 to $31.00 and gave the company an outperform rating in a research note on Monday, March 18th. Finally, Needham & Company LLC reissued a buy rating and set a $29.00 target price on shares of Phreesia in a research note on Friday, May 31st. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, Phreesia presently has a consensus rating of Moderate Buy and a consensus target price of $30.92.

Phreesia Trading Up 0.0 %

Shares of NYSE:PHR opened at $20.51 on Monday. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of -9.45 and a beta of 0.93. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.76 and a current ratio of 1.76. The stock’s 50-day simple moving average is $21.20 and its two-hundred day simple moving average is $23.18. Phreesia has a 52-week low of $12.05 and a 52-week high of $34.98.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, May 30th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.51) by $0.16. Phreesia had a negative return on equity of 46.89% and a negative net margin of 31.87%. The firm had revenue of $101.20 million for the quarter, compared to the consensus estimate of $100.94 million. During the same quarter last year, the company earned ($0.70) earnings per share. The business’s revenue for the quarter was up 20.8% compared to the same quarter last year. Analysts expect that Phreesia will post -1.18 EPS for the current year.

Insider Buying and Selling at Phreesia

In other Phreesia news, insider Janet Gunzburg sold 1,709 shares of the business’s stock in a transaction dated Monday, April 8th. The stock was sold at an average price of $22.62, for a total transaction of $38,657.58. Following the sale, the insider now owns 38,900 shares in the company, valued at approximately $879,918. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Phreesia news, CEO Chaim Indig sold 12,043 shares of the stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $22.62, for a total transaction of $272,412.66. Following the transaction, the chief executive officer now owns 1,225,397 shares in the company, valued at $27,718,480.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Janet Gunzburg sold 1,709 shares of the stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $22.62, for a total value of $38,657.58. Following the transaction, the insider now directly owns 38,900 shares of the company’s stock, valued at approximately $879,918. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 50,359 shares of company stock worth $1,141,645. 5.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in PHR. International Assets Investment Management LLC increased its holdings in shares of Phreesia by 1,987.3% in the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after purchasing an additional 1,411 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in Phreesia during the third quarter worth $53,000. Russell Investments Group Ltd. increased its stake in Phreesia by 5,462.3% during the fourth quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock worth $89,000 after acquiring an additional 3,769 shares during the last quarter. EntryPoint Capital LLC acquired a new stake in Phreesia during the first quarter worth $169,000. Finally, Quadrature Capital Ltd acquired a new stake in Phreesia during the first quarter worth $202,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.